Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction Between PRDM14 and CBFA2T2 Supports Pluripotency and Proliferation in Germ Cell Tumors.

Cancers·2026
Same author

A novel technique for placement of the shunt catheter in the pleural space: The single incision thoracoscopic approach with complete visualization: A patient series and case illustration.

Surgical neurology international·2026
Same author

Post-market surveillance of gelatin-thrombin hemostats in neurosurgery: a 10-year MAUDE Analysis.

Neurological research·2026
Same author

GLP-1 Agonists in Orthopedic Surgery: A Narrative Review of Bone Health and Surgical Implications.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery·2026
Same author

Response to the letter to the editor: Interpreting meta-analyses of biportal endoscopic decompression for lumbar spinal stenosis.

Asian spine journal·2026
Same author

High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma.

Melanoma research·2026

Related Experiment Video

Updated: Sep 3, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K

Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric

Aaron M Taylor1,2,3, Jiayi M Sun2,3, Alexander Yu2

  • 1The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

International Journal of Molecular Sciences
|July 27, 2022
PubMed
Summary

Osteosarcoma gene copy number changes, particularly IGF1R amplification, are common and linked to poor survival in young patients. FGFR2 expression also indicates a worse prognosis.

Keywords:
biomarkerbonecancermetastasisosteosarcomapediatricprognosistreatment

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K

Related Experiment Videos

Last Updated: Sep 3, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Osteosarcoma is a rare bone cancer primarily affecting children and adolescents.
  • Current treatments offer limited improvement in patient survival rates.
  • Understanding the genetic underpinnings of osteosarcoma is crucial for developing new therapies.

Purpose of the Study:

  • To analyze copy number and gene expression profiles in a large cohort of osteosarcoma samples.
  • To identify genetic alterations associated with patient prognosis.
  • To investigate the role of specific genes like IGF1R and FGFR2 in osteosarcoma development and progression.

Main Methods:

  • Genome-wide copy number profiling of 226 osteosarcoma samples.
  • Gene expression profiling of the same samples.
  • Correlation analysis between genetic alterations, gene expression, and patient survival outcomes.

Main Results:

  • Identified widespread and recurrent copy number abnormalities in osteosarcoma.
  • Found prevalent amplification of Insulin growth factor receptor 1 (IGF1R) gene, correlating with increased expression and poor survival.
  • Confirmed associations of other copy number changes (13q34+, 20p13+, 4q35-, 20q13.33-) and highlighted the prognostic significance of high Fibroblast growth factor receptor 2 (FGFR2) expression.

Conclusions:

  • Genetic heterogeneity and copy number abnormalities are characteristic of pediatric osteosarcoma.
  • IGF1R amplification and high FGFR2 expression are significant indicators of poor prognosis in osteosarcoma patients.
  • These findings provide insights into osteosarcoma pathogenesis and potential therapeutic targets.